8 Apr 2021
Eurobiomed
In April 2021, the Strategic Project Council of the Eurobiomed cluster cited, as part of the call for expressions of interest “New biotherapies and production tools”, our phase I/II clinical study project in the context of diffuse large cell B lymphoma (LBDGC), for treatment in autologous immunotherapy.